Company Analysis Bright Health Group, Inc.
1. Summary
Advantages
- Price (6.53 $) is less than fair price (9.84 $)
- The stock's return over the last year (25.34%) is higher than the sector average (-20.75%).
- The company's current efficiency (ROE=-68.41%) is higher than the sector average (ROE=-80.87%)
Disadvantages
- Dividends (0%) are below the sector average (1.28%).
- Current debt level 6.51% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Bright Health Group, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -17% | 2.3% |
| 90 days | 0% | -26.4% | 5.2% |
| 1 year | 25.3% | -20.8% | 27% |
BHG vs Sector: Bright Health Group, Inc. has outperformed the "Healthcare" sector by 46.09% over the past year.
BHG vs Market: Bright Health Group, Inc. has underperformed the market marginally by -1.65% over the past year.
Stable price: BHG is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BHG with weekly volatility of 0.4872% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (6.53 $) is lower than the fair price (9.84 $).
Price significantly below the fair price: The current price (6.53 $) is 50.7% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (57.85).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (47.37).
4.3. P/BV
P/BV vs Sector: The company's P/BV (28.56) is higher than that of the sector as a whole (9.39).
P/BV vs Market: The company's P/BV (28.56) is higher than that of the market as a whole (22.69).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (11.13) is higher than that of the sector as a whole (4.05).
P/S vs Market: The company's P/S indicator (11.13) is lower than that of the market as a whole (15.16).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-62.72) is lower than that of the sector as a whole (17.49).
EV/Ebitda vs Market: The company's EV/Ebitda (-62.72) is lower than that of the market as a whole (17.77).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 234.49% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (234.49%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-14.25%).
5.4. ROE
ROE vs Sector: The company's ROE (-68.41%) is higher than that of the sector as a whole (-80.87%).
ROE vs Market: The company's ROE (-68.41%) is lower than that of the market as a whole (17.13%).
5.5. ROA
ROA vs Sector: The company's ROA (-15.44%) is lower than that of the sector as a whole (6.7%).
ROA vs Market: The company's ROA (-15.44%) is lower than that of the market as a whole (6.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-620.45%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (-620.45%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.28%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
